A phase II clinical trial of Bifidobacterium longum subsp. longum BL21 for preventing acute radiation enteritis among pelvic radiotherapy patients.
- 2025-11-10
- Clinical Trial · n = 52
- Frontiers in nutrition 12
- Yinyin Yang
- Xuhao Gu
- Chang Liu
- Li Zou
- Liwei Xie
- Yulong Liu
- Peifeng Zhao
- Ye Tian
- Shang Cai
- PubMed: 41293184
- DOI: 10.3389/fnut.2025.1626169
- High evidence
the increase in BL21 was associated with greater alpha diversity, an increase in beneficial bacteria, and a decrease in harmful bacteria
- Effect
- Beneficial
- Effect size
- Small